126 related articles for article (PubMed ID: 21178355)
1. Effect of psychiatric severity on the outcome of methadone maintenance treatment.
Pani PP; Maremmani I; Pacini M; Lamanna F; Maremmani AG; Dell'osso L
Eur Addict Res; 2011; 17(2):80-9. PubMed ID: 21178355
[TBL] [Abstract][Full Text] [Related]
2. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
3. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
[TBL] [Abstract][Full Text] [Related]
4. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
Ngo HT; Tait RJ; Hulse GK
J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.
Eiroa-Orosa FJ; Haasen C; Verthein U; Dilg C; Schäfer I; Reimer J
Drug Alcohol Depend; 2010 Dec; 112(3):226-33. PubMed ID: 20708349
[TBL] [Abstract][Full Text] [Related]
6. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
Pinto H; Maskrey V; Swift L; Rumball D; Wagle A; Holland R
J Subst Abuse Treat; 2010 Dec; 39(4):340-52. PubMed ID: 20817384
[TBL] [Abstract][Full Text] [Related]
7. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.
Carpentier PJ; van Gogh MT; Knapen LJ; Buitelaar JK; De Jong CA
Eur Addict Res; 2011; 17(1):10-20. PubMed ID: 20881401
[TBL] [Abstract][Full Text] [Related]
8. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
9. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence.
Karow A; Verthein U; Pukrop R; Reimer J; Haasen C; Krausz M; Schäfer I
Subst Use Misuse; 2011; 46(6):705-15. PubMed ID: 21047149
[TBL] [Abstract][Full Text] [Related]
10. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and improvement in psychopathology in opioid dependent patients participating in methadone maintenance.
Musselman DL; Kell MJ
J Addict Dis; 1995; 14(3):67-82. PubMed ID: 8555280
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
[TBL] [Abstract][Full Text] [Related]
13. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity.
Maremmani I; Zolesi O; Aglietti M; Marini G; Tagliamonte A; Shinderman M; Maxwell S
J Addict Dis; 2000; 19(2):29-41. PubMed ID: 10809518
[TBL] [Abstract][Full Text] [Related]
14. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
[TBL] [Abstract][Full Text] [Related]
15. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
Maremmani I; Pacini M; Lubrano S; Perugi G; Tagliamonte A; Pani PP; Gerra G; Shinderman M
Eur Addict Res; 2008; 14(3):134-42. PubMed ID: 18552489
[TBL] [Abstract][Full Text] [Related]
17. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
18. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
[TBL] [Abstract][Full Text] [Related]
19. [The impact of substitution treatment by methadone among opiate-dependent subjects evaluated by Addiction Severity Index and by urine tests].
Trémeau F; Darreye A; Khidichian F; Weibel H; Kempf M; Greth P; Schneider JL; Wantz C; Weber B; Stépien S; Macher JP
Encephale; 2002; 28(5 Pt 1):448-53. PubMed ID: 12386547
[TBL] [Abstract][Full Text] [Related]
20. Main reasons for hospital admissions by women with a history of methadone maintenance.
Burns L; Conroy E; Mattick RP
Drug Alcohol Rev; 2010 Nov; 29(6):669-75. PubMed ID: 20973853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]